Literature DB >> 2070065

Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.

G Socié1, M Henry-Amar, J M Cosset, A Devergie, T Girinsky, E Gluckman.   

Abstract

From May 1980 to December 1989, 107 consecutive patients with non-constitutional severe aplastic anemia underwent bone marrow transplantation at our institution using cyclophosphamide and thoraco-abdominal irradiation as conditioning regimen. During the same period, 40 patients with Fanconi anemia were also grafted after a similar conditioning, giving a total series of 147 patients. With a mean follow-up of 64 months, four male patients developed a solid malignant tumor, a number that leads to an 8-year cumulative incidence rate of 22% (eg, relative risk to general population = 41, P less than .001). These results should be considered as a warning to clinicians who follow these successfully grafted long-term patients.

Entities:  

Mesh:

Year:  1991        PMID: 2070065

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

Review 2.  Clinical radiation sensitivity with DNA repair disorders: an overview.

Authors:  Julianne M Pollard; Richard A Gatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

Review 3.  Late effects of total body irradiation.

Authors:  A D Leiper
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

4.  Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.

Authors:  André Tichelli; Eric Beohou; Myriam Labopin; Gérard Socié; Alicia Rovó; Manuela Badoglio; Anja van Biezen; Peter Bader; Rafael F Duarte; Grzegorz Basak; Nina Salooja
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

5.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.

Authors:  Rochelle E Curtis; Catherine Metayer; J Douglas Rizzo; Gérard Socié; Kathleen A Sobocinski; Mary E D Flowers; William D Travis; Lois B Travis; Mary M Horowitz; H Joachim Deeg
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

6.  Autoimmunity and the risk of myeloproliferative neoplasms.

Authors:  Sigurdur Y Kristinsson; Ola Landgren; Jan Samuelsson; Magnus Björkholm; Lynn R Goldin
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

7.  Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.

Authors:  Marco Marziali; Antonella Isgrò; Javid Gaziev; Guido Lucarelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-26       Impact factor: 2.576

8.  Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia.

Authors:  Yun-Hee Lee; Ji-Yoon Kim; Byung-Ock Choi; Mi-Ryeong Ryu; Su-Mi Chung
Journal:  Radiat Oncol J       Date:  2012-12-31

9.  Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

Authors:  David Buchbinder; Diane J Nugent; Ruta Brazauskas; Zhiwei Wang; Mahmoud D Aljurf; Mitchell S Cairo; Robert Chow; Christine Duncan; Lamis K Eldjerou; Vikas Gupta; Gregory A Hale; Joerg Halter; Brandon M Hayes-Lattin; Jack W Hsu; David A Jacobsohn; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Paulette Mehta; Kasiani C Myers; Susan K Parsons; Jakob R Passweg; Joseph Pidala; Vijay Reddy; Carmen M Sales-Bonfim; Bipin N Savani; Adriana Seber; Mohamed L Sorror; Amir Steinberg; William A Wood; Donna A Wall; Jacek H Winiarski; Lolie C Yu; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-01       Impact factor: 5.742

10.  Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.

Authors:  M Horstmann; M Stockschläder; W Krüger; M Hoffknecht; R Betker; H Kabisch; A Zander
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.